SAMeTT2R2 does not predict time in therapeutic range of the international normalized ratio in patients attending a high-quality anticoagulation clinic

Chest

Volumn 145, Issue 1, 2014, Pages 187-188

  Skov, Jane ^a   Bladbjerg, Else Marie ^a   Bor, Mustafa Vakur ^a   Gram, Jørgen ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; ANTIVITAMIN K;

AGE; ALCOHOL CONSUMPTION; ANTICOAGULANT THERAPY; CLINICAL ASSESSMENT TOOL; COMORBIDITY; DRUG USE; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH CARE FACILITY; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; MEDICAL PARAMETERS; PREDICTION; PRIORITY JOURNAL; SAMETT2T2 SCORE; SCORING SYSTEM; SMOKING; STRESS; TIME IN THERAPEUTIC RANGE; TREATMENT OUTCOME; TREATMENT PLANNING;

ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; QUALITY INDICATORS, HEALTH CARE; STROKE; WARFARIN;

EID: 84892654542     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1897     Document Type: Letter

References (5)

1. Apostolakis S, Sullivan RM, Olshansky B, Lip GYH. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT 2 R 2 score. Chest. 2013; 144 (5): 1555-1563.
2. Skov J, Leppin A, Bladbjerg EM, Sidelmann JJ, Gram J. Perceived stress predicts the stability of vitamin K-antagonist treatment of anticoagulant clinic patients. Thromb Haemost. 2012; 108 (3): 581-582.
3. Skov J, Bladbjerg EM, Leppin A, Jespersen J. The influence of VKORC1 and CYP2C9 gene sequence variants on the stability of maintenance phase warfarin treatment. Thromb Res. 2013; 131 (2): 125-129.
4. Wallentin L, Lopes RD, Hanna M, et al Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation. 2013; 127(22): 2166- 2176.
5. Kirchhof P, Nabauer M, Gerth A, et al; AFNET registry investigators. Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions. Thromb Haemost. 2011; 105 (6): 1010-1023.